About BioPortfolio

Biotech stocks are notoriously volatile as they react quickly and significantly to investor expectations. At BioPortfolio, we generate alpha by pinpointing exactly where that expectation is. Deploying TipRanks’ award-winning algorithm, we highlight the coming week’s best biotech stock picks by gathering the most extensive data available on the universe of biotech stocks. Once a particular stock exceeds its average publicity threshold, it will trigger a signal.

For example, Gilead Sciences, Inc. (NASDAQ: GILD) is a very well-covered stock, mentioned in hundreds of articles on a daily basis. It would take a very strong positive or negative sentiment to produce enough material for our system to detect it as having a positive or negative outlook. However, when a less-covered biotech stock suddenly begins to receive a lot of positive coverage, it will trigger our system. Out of all the stocks that are triggered by these signals, the two with the most bullish sentiments and one with the most bearish sentiment will be featured on the BioPortfolio newsletter.

Our measuring assumes you are 100% invested, with the value split evenly between our top two picks (50%/50%). A further 50% leveraged investment is allocated to our short pick, ensuring some level of market neutrality to the overall sector risk. Since the beginning of 2011, BioPortfolio has generated nearly 1,000% in compounding returns and is still going strong.

The newsletter is sent every Monday morning at 9AM EST, giving you plenty of time to evaluate the weekly picks before the market opens. BioPortfolio is simple to maintain because most picks only require rebalancing every 3-4 weeks, making it suitable for both beginner and veteran investors. Due to the very large swings, we highly recommend making BioPortfolio a portion of your overall investment strategy. Potential picks (universe) includes all US biotech stocks with a market capitalization above $100 million and share price above $4.00.